Loading…
Lobbying Spend
—
Filings
33
Firms Hired
2
Active Period
2012–2020
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Preserving Patient Access to Compounded Medications Act of 2017
2018 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Drug Quality and Security Act, Pub. L. 113-54; FDA regulatory implementation of Section 503B of the Food, Drug and Cosmetic Act; FDA Pharmacy Compounding Advisory Committee; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $100,000
Matched citations: H.R. 2871
Preserving Patient Access to Compounded Medications Act of 2017
2018 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Drug Quality and Security Act, Pub. L. 113-54; FDA regulatory implementation of Section 503B of the Food, Drug and Cosmetic Act; FDA Pharmacy Compounding Advisory Committee; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $100,000
Matched citations: H.R. 2871
Preserving Patient Access to Compounded Medications Act of 2017
2017 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Drug Quality and Security Act, Pub. L. 113-54; FDA regulatory implementation of Section 503B of the Food, Drug and Cosmetic Act; FDA Pharmacy Compounding Advisory Committee; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $70,000
Matched citations: H.R. 2871
Preserving Patient Access to Compounded Medications Act of 2017
2017 · fourth_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Drug Quality and Security Act, Pub. L. 113-54; FDA regulatory implementation of Section 503B of the Food, Drug and Cosmetic Act; FDA Pharmacy Compounding Advisory Committee; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $70,000
Matched citations: H.R. 2871
Preserving Patient Access to Compounded Medications Act of 2017
2017 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Drug Quality and Security Act, Pub. L. 113-54; FDA regulatory implementation of Section 503B of the Food, Drug and Cosmetic Act; FDA Pharmacy Compounding Advisory Committee; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2871
Preserving Patient Access to Compounded Medications Act of 2017
2017 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Drug Quality and Security Act, Pub. L. 113-54; FDA regulatory implementation of Section 503B of the Food, Drug and Cosmetic Act; FDA Pharmacy Compounding Advisory Committee; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2871
Preserving Patient Access to Compounded Medications Act of 2017
2017 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Drug Quality and Security Act, Pub. L. 113-54; FDA regulatory implementation of Section 503B of the Food, Drug and Cosmetic Act; FDA Pharmacy Compounding Advisory Committee; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2871
Preserving Patient Access to Compounded Medications Act of 2017
2017 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Drug Quality and Security Act, Pub. L. 113-54; FDA regulatory implementation of Section 503B of the Food, Drug and Cosmetic Act; FDA Pharmacy Compounding Advisory Committee; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2871
Source: Senate LDA